In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution

被引:10
作者
Devereux, HL
Burke, A
Lee, CA
Johnson, MA
机构
[1] UCL Royal Free & Univ Coll, Sch Med, HIV AIDS Clin Unit, London, England
[2] UCL Royal Free & Univ Coll, Sch Med, Haemophilia & Haemostasis Unit, London, England
[3] UCL Royal Free & Univ Coll, Sch Med, Dept Retrovirol, London, England
关键词
antiretroviral therapy; HIV resistance mutations; postmortem tissues; compartmentalisation;
D O I
10.1002/jmv.2104
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Four patients who had received highly active antiretroviral therapy (HAART), and had postmortem samples stored, were tested for genotypic resistance using consensus sequencing. One patient was further investigated using single-copy sequencing. Patients 1, 3, and 4 showed a relatively uniform distribution of resistance associated mutations, with only a small number (one to three) of protease mutations detectable. Patient 2 had a number of detectable mutations (four to eight, depending on the tissue) with similar distributions between the tissues. The exception was viruses detected in the esophagus, which were more diverse. Plasma was a moderately representative tissue of the viruses circulating in these individuals. However, some mutations detectable in some tissues were not seen in plasma (e.g., M461 and D30N in the protease). Single-copy sequencing revealed a wide distribution of quasi-species and a number of defective viruses in the proviral DNA and RNA. This study supports the concept that a wide variety of quasi-species circulate in each individual and that there may be viruses evolving independently in different body compartments. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:8 / 12
页数:5
相关论文
共 16 条
[1]  
Atkins M, 1998, J MED VIROL, V55, P138, DOI 10.1002/(SICI)1096-9071(199806)55:2&lt
[2]  
138::AID-JMV10&gt
[3]  
3.0.CO
[4]  
2-E
[5]  
BAXTER JD, 1999, 6 C RETR OPP INF CHI
[6]   REVERSE-TRANSCRIPTASE SEQUENCE OF PAIRED ISOLATES OF CEREBROSPINAL-FLUID AND BLOOD FROM PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING ZIDOVUDINE TREATMENT [J].
DISTEFANO, M ;
SABRI, F ;
LEITNER, T ;
SVENNERHOLM, B ;
HAGBERG, L ;
NORKRANS, G ;
CHIODI, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) :352-355
[7]   Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial [J].
Durant, J ;
Clevenbergh, P ;
Halfon, P ;
Delgiudice, P ;
Porsin, S ;
Simonet, P ;
Montagne, N ;
Boucher, CAB ;
Schapiro, JM ;
Dellamonica, P .
LANCET, 1999, 353 (9171) :2195-2199
[8]   Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission [J].
Eron, JJ ;
Vernazza, PL ;
Johnston, DM ;
Seillier-Moiseiwitsch, S ;
Alcorn, TM ;
Fiscus, SA ;
Cohen, MS .
AIDS, 1998, 12 (15) :F181-F189
[9]  
Günthard HF, 1998, J VIROL, V72, P2422
[10]   Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].
Hirsch, MS ;
Conway, B ;
D'Aquila, RT ;
Johnson, VA ;
Brun-Vézinet, F ;
Clotet, B ;
Demeter, LM ;
Hammer, SM ;
Jacobsen, DM ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Vella, S ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991